You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dutasteride

Showing 1 - 25 of 151
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Androgenic Alopecia Trial in São José dos Campos (MESOTHERAPY (INJECTIONS WITH SYRINGE AND NEEDLE), MMP (INJECTIONS WITH A

Recruiting
  • Androgenic Alopecia
  • MESOTHERAPY (INJECTIONS WITH SYRINGE AND NEEDLE)
  • MMP (INJECTIONS WITH A TATTOO MACHINE)
  • São José dos Campos, São Paulo, Brazil
    Clinica Dermatologica Arbache
Oct 30, 2023

Prostatic Hyperplasia, Prostate Cancer Trial in Turku (Prostate hyperplasia medication, LhRH-antagonist)

Recruiting
  • Prostatic Hyperplasia
  • Prostate Cancer
  • Turku, Finland
  • +1 more
Aug 17, 2023

Male Androgenetic Alopecia Trial in Madrid (Dutasteride, Placebo)

Recruiting
  • Male Androgenetic Alopecia
  • Dutasteride
  • Placebo
  • Madrid, Spain
    Hospital Ramón y Cajal
Oct 25, 2022

Alcohol Use Disorder Trial in Farmington (Dutasteride Capsules, Placebo Capsules)

Recruiting
  • Alcohol Use Disorder
  • Dutasteride Capsules
  • Placebo Capsules
  • Farmington, Connecticut
    University of Connecticut Health Center
Jun 14, 2022

Salivary Duct Carcinoma Trial in Nijmegen (Goserelin 10.8 mg, Bicalutamide 50 mg, Dutasteride 0.5 mg)

Not yet recruiting
  • Salivary Duct Carcinoma
  • Goserelin 10.8 mg
  • +2 more
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Aug 23, 2022

Prostate Cancer Trial (Dutasteride, Abiraterone)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
Jan 30, 2023

Prostatic Tumors, Low Grade Prostate Cancer Trial in Quebec (Dietary intervention first, Drug (Dutasteride) intervention first)

Active, not recruiting
  • Prostatic Neoplasms
  • Low Grade Prostate Cancer
  • Dietary intervention first
  • Drug (Dutasteride) intervention first
  • Quebec, Canada
  • +1 more
Mar 14, 2022

Prostate Cancer Trial in Rochester (Enzalutamide and Dutasteride)

Active, not recruiting
  • Prostate Cancer
  • Enzalutamide and Dutasteride
  • Rochester, New York
    University of Rochester
Nov 2, 2021

Disease Control and Quality of Life in Benign PROStatic

Recruiting
  • Benign Prostatic Hyperplasia
  • Patients with Benign Prostate Hyperplasia
  • Athens, Greece
    Laikon Hospital of Athens
Jul 12, 2022

Benign Prostatic Hyperplasia Trial in Seoul (DKF-313, Dutasteride, Tadalafil)

Recruiting
  • Benign Prostatic Hyperplasia
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 9, 2021

Dutasteride, Category IIIB Chronic Prostatitis Trial in Cairo (Dutasteride 0.5 mg, Placebo)

Completed
  • Dutasteride
  • Category IIIB Chronic Prostatitis
  • Dutasteride 0.5 mg
  • Placebo
  • Cairo, Egypt
    Urology department - ain shams university
Feb 11, 2021

Prostate Cancer Trial in Kogarah, Liverpool, Bedford Park (PCUR-101, Dutasteride 0.5 mg, Abiraterone and Prednisone)

Recruiting
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +4 more
Jan 6, 2023

Covid19 Trial in Brasília (Dutasteride 0.5 mg, Azithromycin, Nitazoxanide)

Completed
  • Covid19
  • Dutasteride 0.5 mg
  • +3 more
  • Brasília, DF, Brazil
    Corpometria Institute
Jan 25, 2021

Prostate Cancer Trial in Chicago (Bicalutamide, Dutasteride, Finasteride)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Chicago, Illinois
    University of Chicago
Sep 30, 2021

Benign Prostate Hyperplasia, Healthy Trial in Jeonju (DKF-313, AVODART, CIALIS)

Completed
  • Benign Prostate Hyperplasia
  • Healthy
  • Jeonju, Jeollabuk-do, Korea, Republic of
    Chonbuk National University Hospital
Jul 1, 2021

Transgenderism, Hypogonadism Trial (dutasteride 5 mg/day, Testosterone Undecanoate)

Completed
  • Transgenderism
  • Hypogonadism
  • dutasteride 5 mg/day
  • Testosterone Undecanoate
  • (no location specified)
Sep 3, 2020

Dutasteride on Architectural and Nuclear Morphometric Features

Completed
  • Benign Prostate Tissue
    • Chicago, Illinois
      University of Illinois at Chicago
    Oct 1, 2020

    Digital Morphometry for Cancer Risk in Benign Prostate Biopsies

    Completed
    • Prostate Cancer
    • Dutasteride
    • Placebo
    • Chicago, Illinois
      University of Illinois at Chicago
    Oct 9, 2020

    Premenstrual Syndrome, PMS, Healthy Trial run by the NIMH (Dutasteride, Placebo oral capsule)

    Completed
    • Premenstrual Syndrome
    • +3 more
    • Dutasteride
    • Placebo oral capsule
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 14, 2019

    Gonadotropin Deficiency Trial in Seattle (Testosterone 1% Gel, Acyline, Dutasteride)

    Withdrawn
    • Gonadotropin Deficiency
    • Testosterone 1% Gel
    • +6 more
    • Seattle, Washington
      University of Washington Medical Center (Health Sciences)
    Dec 16, 2019

    Alcoholism, Alcohol Abuse, Alcohol Dependence Trial in Farmington (Dutasteride, sugar pill)

    Completed
    Has Results
    • Alcoholism
    • +2 more
    • Dutasteride
    • sugar pill
    • Farmington, Connecticut
      University of Connecticut Health Center
    Apr 11, 2019

    Prostatic Hyperplasia, Benign, Metabolic Syndrome Trial in A Coruña (Caloric Restriction, Control)

    Withdrawn
    • Prostatic Hyperplasia, Benign
    • Metabolic Syndrome
    • Caloric Restriction
    • Control
    • A Coruña, Spain
      Jose Luis Ponce Diaz-Reixa
    Jul 26, 2021

    Amyotrophic Lateral Sclerosis Trial in Valencia (dietary supplement, other, drug)

    Recruiting
    • Amyotrophic Lateral Sclerosis
    • Liposomed polyphenols resveratrol and curcumin
    • +4 more
    • Valencia, Spain
      José Enrique de la Rubia Ortí
    Aug 3, 2022

    Androgenetic Alopecia Trial in Daegu (AD-208, Avodart Soft Capsule 0.5mg)

    Completed
    • Androgenetic Alopecia
    • AD-208
    • Avodart Soft Capsule 0.5mg
    • Daegu, Korea, Republic of
      Kyungpook National University Hospital
    Dec 1, 2020

    Urologic Diseases Trial in Belfast (Commercially available combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg, Second

    Completed
    • Urologic Diseases
    • Commercially available combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg
    • Second generation dutasteride 0.5 mg and tamsulosin HCL 0.4 mg combination capsule
    • Belfast, United Kingdom
      GSK Investigational Site
    Sep 11, 2018